vimarsana.com
Home
Live Updates
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers : vimarsana.com
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers : vimarsana.com
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers
Funding also supports the start of phase I/IIa study for lead vaccine, ITOP1
Related Keywords
United Kingdom ,
London ,
City Of ,
Nicola Ternette ,
Hugo Villanueva ,
Mark Middleton ,
Paul Klenerman ,
Johnw Cassidy ,
Phil Masterson ,
Jonathan Kwok ,
Julia Schrameier ,
Cancer Research Horizon ,
Cancer Foundation ,
Cancer Research United Kingdom ,
Regulatory Agency ,
Cancer Research Institute ,
United Kingdom Future Economy Investor Partnership ,
Cancer Research Horizons ,
Oxford University ,
Infinitopes Precision Immunomics ,
Kindred Capital ,
Manta Ray ,
Martlet Capital ,
Meltwind Advisory ,
Saras Capital ,
Wilbe Capital ,
Innovate United Kingdom ,
Future Economy Investor Partnership ,
Innovative Licensing ,
Access Pathway ,
Cancer Research United ,
Professor Paul Klenerman ,
Associate Professor Nicola Ternette ,
Professor Mark ,
Big Pharma ,
Associate Director ,
Research Horizon ,
Octopus Ventures ,
General Partner ,
Immuno Oncology Europe ,
European Neoantigen Summit ,
San Sebasti ,